Loading
institutionsInstitution
Curanosticum Wiesbaden-Frankfurt
Curanosticum is a nuclear medicine practice in Wiesbaden and Frankfurt led by Richard Baum, one of the pioneers of peptide receptor radionuclide therapy, offering FAPI PET and investigational radioligand therapies.
Overview
Curanosticum Wiesbaden-Frankfurt describes itself as modern nuclear medicine in the Rhine-Main region: precise diagnostics and individual therapy from an experienced team. Led by Richard Baum, it offers FAPI PET imaging and investigational radioligand therapies alongside established theranostics, and is patient-bookable through an oncology referral.
Location
Wiesbaden, DE
Type
hospital
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#501 · 6 points (0 Newsweek + 0 NCI + 6 from 3 linked objects) · ranking
Similar pages
- InstitutionExcel Diagnostics and Nuclear Oncology Center
Shares Radioligand therapy (beta emitters) and the tag fcct-directory.
- TrialAn Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
- TrialA Study of 177Lu-FAP-2286 in Advanced Solid Tumors
- TechnologyRadioligand dosimetry
Shares Lutetium-177 radioligand therapy, Radioligand therapy (beta emitters).
- PersonWolfgang A. Weber
- TrialAnti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
- TrialStudy to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, o
- InstitutionPostgraduate Institute of Medical Education and Research, Chandigarh